KAHIRA PHARMACEUTICALS&CHEMICAL INDUSTRS Inactive Instrument
Kahira Pharmaceuticals&Chemical Industrs Stock Egyptian Exchange
Equities
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Sales 2022 | 1.11B 23.27M 0 | Sales 2023 | 1.01B 21.03M 0 | Capitalization | 637M 13.32M 0 |
|---|---|---|---|---|---|
| Net income 2022 | 166M 3.47M - | Net income 2023 | 97M 2.03M - | EV / Sales 2022 | 0.45 x |
| Net cash position 2022 | 53.52M 1.12M 0 | Net Debt 2023 | 28.62M 599K 0 | EV / Sales 2023 | 0.66 x |
| P/E ratio 2022 |
3.33
x | P/E ratio 2023 |
6.56
x | Employees | - |
| Yield 2022 |
13.5% | Yield 2023 |
11.7% | Free-Float | 18.53% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 21-06-01 | |
| Director of Finance/CFO | - | - | |
| Corporate Secretary | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 21-06-01 | |
| Chief Executive Officer | - | 21-06-01 | |
| Director/Board Member | - | 21-06-01 |
Cairo Pharmaceuticals specializes in manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, parasitic, dermatological, cardiovascular, allergic diseases, etc. The group also provides veterinary products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +34.00% | 664B | |
| +29.29% | 567B | |
| -7.75% | 354B | |
| +18.53% | 330B | |
| +4.95% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.89% | 148B |
